/2562 นำส่งสำเนาประกาศและซักซ้อมความเข้าใจเกี่ยวกับแนวทางการกำกับดูแลเรื่องการป้องกันและจัดการความขัดแย้งทางผลประโยชน์ 08/03/2562 16/03/2562 5. หนังสือเวียน นำส่งแนวนโยบายร่วม (Joint Policy Statement
, consolidated financial statement has net loss of Baht 41 million and net profit of Baht 39 million, respectively. This was resulted from non-core business transaction of the Company, which is accounted for Baht
-month period ended 30 June 2020 and 2019, consolidated financial statement has net profit of Baht 4 million and Baht 48 million, respectively. This was resulted from the effect of the outbreak of
of 2020. The Company (iiG) and ICE/iiXP (the subsidiaries), recorded the total Assets of 443.14 Mb.and 480.68 Mb respectively. The current assets presented in the audited financial statement consist of
per share (Baht) 0.08 - 100.0% Remark : EBITDA = Profit before finance costs, income tax, Depreciation and Amortization Statement of Income : Million Baht ZIGA INNOVATION PUBLIC COMPANY LIMITED 999
Siwarapornskul Funding Source: Internal working capital of the Company Share Transfer Date: 31 March 2020 Hence, according to the Company’s latest consolidated financial statement ended 31 December 2019, the total
) (1.50) 14.76% 438.69 474.69 (35.99) -8.20% เพิ่ม (ลด) TOTAL ASSETS TOTAL LIABILITIES TOTAL SHAREHOLDERS' EQUITY Statement of Financial Position For Quarter 1 Year 2020 (Million Baht) 5 | MANAGEMENT
02-634-0135 www.interpharma.co.th 4. MP Financial Statement Balance Sheet (Unit : Baht) 2017 Audited Statement 2018 Audited Statement 2019 Audited Statement Assets Current Assets Cash and cash
with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000